Industry litigation – Page 19
-
Business
Lundbeck appeals European antitrust fine
Danish pharmaceutical claims €93.8 million pay-for-delay penalty was the result of ‘serious legal and factual errors’
-
Business
Syngenta takes legal action over pesticide ban
Company claims that the European commission’s two-year moratorium on neonicotinoids to protect bees was wrong
-
Business
Couple charged in GSK corruption investigation
Two private investigators have been charged with breaching the privacy rights of Chinese citizens
-
BusinessObama mandate calls for safer chemical facilities
Agencies need to work together more effectively to improve safety
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessLilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
GSK under investigation over corruption in China
Police claim executives engaged in bribery and tax-related crimes
-
BusinessTexas plant explosion prompts calls for stricter rules
The incident was caused by unregulated and improper storage of ammonium nitrate, investigators find
-
Business
Biosimilar drugs step up complexity
First generic monoclonal antibodies recommended for approval in Europe
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
Business
NHS to offer breast cancer prevention drugs
Five-year course of tamoxifen or raloxifene recommended for high risk women
-
Business
Companies urged to publish hidden clinical trial data
Researchers could acquire data and publish themselves if firms refuse
-
Business
GSK fires Chinese R&D head in data investigation
Company is retracting a 2010 study in which data were ‘misrepresented’
-
Business
Pfizer and Takeda win $2.15bn in patent payout
Teva and Sun fined for selling generics before patent expiry
-
Business
Big data to sniff out drug marketing fraud
US Food and Drug Administration wants to track promotional spending to spot off-label marketing
-
Business
$500m fine over generics fraud for Ranbaxy
Company has pleaded guilty to fabricating data and producing substandard drugs
-
Business
GSK partners Save the Children for Africa project
Company and charity will work together to provide medicines for the developing world
-
BusinessClinical trial data release blocked by companies
Abbvie and Intermune sue the European Medicines Agency to stop it making data public